Source:http://linkedlifedata.com/resource/pubmed/id/10191321
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
8
|
pubmed:dateCreated |
1999-4-27
|
pubmed:abstractText |
Treatment with NGF causes long-term cultures of oligodendrocytes to die via a yet undefined mechanism mediated by the p75 neurotrophin receptor. The p75 receptor belongs to the TNF receptor superfamily of molecules, which includes Fas and p55 TNF receptors. The Fas and TNF receptors use adaptor molecules to recruit and activate caspase-8 to the receptor. Using a combination of immunohistochemical and Western blotting assays, we have examined caspase activity during NGF-induced apoptosis. Interestingly, although caspase-1 [interleukin-1beta-converting enzyme (ICE)], caspase-2, caspase-3, and caspase-8 were expressed in oligodendrocytes, only caspase-1, -2, and -3 were activated after NGF treatment, whereas caspase-8 was not. These data suggest that the mechanism of apoptosis by NGF through the p75 receptor is different from TNF and Fas-mediated killing. gamma Radiation of oligodendrocytes also activated a similar subset of caspases as NGF, indicating that NGF-induced oligodendrocyte apoptosis uses a similar cell death execution mechanism as injury models. This consolidates a potential role of the p75 neurotrophin receptor during stress and inflammatory conditions.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Casp3 protein, rat,
http://linkedlifedata.com/resource/pubmed/chemical/Caspase 3,
http://linkedlifedata.com/resource/pubmed/chemical/Caspases,
http://linkedlifedata.com/resource/pubmed/chemical/Enzyme Inhibitors,
http://linkedlifedata.com/resource/pubmed/chemical/Receptor, Nerve Growth Factor,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Nerve Growth Factor
|
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
0270-6474
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
15
|
pubmed:volume |
19
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
3043-9
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:10191321-Animals,
pubmed-meshheading:10191321-Apoptosis,
pubmed-meshheading:10191321-Caspase 3,
pubmed-meshheading:10191321-Caspases,
pubmed-meshheading:10191321-Cells, Cultured,
pubmed-meshheading:10191321-Enzyme Activation,
pubmed-meshheading:10191321-Enzyme Inhibitors,
pubmed-meshheading:10191321-In Situ Nick-End Labeling,
pubmed-meshheading:10191321-Oligodendroglia,
pubmed-meshheading:10191321-Rats,
pubmed-meshheading:10191321-Rats, Sprague-Dawley,
pubmed-meshheading:10191321-Receptor, Nerve Growth Factor,
pubmed-meshheading:10191321-Receptors, Nerve Growth Factor
|
pubmed:year |
1999
|
pubmed:articleTitle |
Oligodendrocyte apoptosis mediated by caspase activation.
|
pubmed:affiliation |
Cell Biology Program, Weill Graduate School of Cornell University Medical College, New York, New York 10021, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't
|